You may have learned about Evorel Conti patches if you’ve mentioned using menopause (HRT) medications to relieve the physical symptoms and psychological consequences of menopause with your doctor. This is a combined version of hormone replacement therapy (HRT) for postmenopausal women who are experiencing signs of menopause. But should you be concerned about Evorel Conti’s bleeding?
What Is Evorel Conti?
Evorel Conti is a hormone replacement drug that is used indefinitely (HRT). Each patch has estradiol and norethisterone. These two active ingredients are released into the blood daily and mimic the two female sex hormones, oestrogen, and progesterone.
Post-menopausal women, those who have already entered menopause and haven’t had a regular cycle for a year yet still have menopausal symptoms — can take continuous cumulative HRTs, including Evorel Conti. It does not mean that taking Evorel Conti does not require a monthly cycle or time. Evorel Conti bleeding, on the other hand, is still mentioned as a risk factor of this HRT. During the first months on treatment, certain users will experience spotting or bleeding. Bleeding from Evorel Conti patches is usually not a cause for concern. As the body adjusts to the new hormonal changes and things relax, this side effect can fade.
Consult the doctor if your bleeding persists after this period, if it resumes after you are consuming these patches for months and if you have Evorel Conti moderate bleeding, or whether you have bleeding after stopping the medication.
Can Evorel Conti result in weight gain?
One of the most frequent adverse effects of the HRT drug Evorel Conti is weight gain. It’s also important to note that there’s no scientific research to back up the argument that HRT causes weight gain. Females may gain weight during menopause, but this is common regardless of whether they are taking HRT.
What are the Evorel Conti side effects?
Evorel Conti patches, like other drugs, can lead to side effects. This isn’t to say that anyone who takes Evorel Conti will have side effects. Most consumers report that Evorel Conti patches significantly reduce menopausal symptoms and have no harmful side effects. For those that do, the gains usually outweigh the negative consequences.
In any case, it’s good to be mindful of any potential adverse effects while taking any medication. The following are the most common Evorel Conti patch side effects (which affect less than 1 in 10 people):
- Feeling of dizziness
- Tenderness and pain in the breast
- Feeling depressed, anxious, or nervous
- Sleeping problems
- Nauseous (feeling sick)
- Pain in the head
- Stomach ache or nausea
- Muscle aches and twitching.
- Joint discomfort
- Skin bleeding
- Random discharge from the vagina.
Those mentioned above are some of the most common side effects of Evorel Patches, unless they are serious, they do not necessitate medical treatment. Nevertheless, if you have any concerns about any of these complications, or any others not mentioned above, consult with your doctor or pharmacist.
Are there any Evorel Conti alternatives?
If you’re searching for Evorel Conti alternatives or are having trouble choosing between different HRTs, learning more about the various forms of HRT treatments is an excellent place to start.
Continuous combined Hormone Replacement Therapy:
Continuous combined HRT (such as Evorel Conti patches) is a form of HRT that is suggested for postmenopausal women who haven’t had a cycle in over a year. Continuous combination HRT entails consuming both oestrogen and progestogen on a daily basis without interruption. Femseven Conti patches are the most comparable HRT patches to Evorel Conti patches.
Cyclical Hormone Replacement Therapy:
This type of therapy is made up of two kinds of patches or tablets: one that only releases oestrogen and the other that releases both oestrogen and progestogen. In a monthly therapy period, the oestrogen-only patches are used for the first two weeks, and the mixed patches are used for the second half.
Oestrogen-only Hormone Replacement Therapy:
Oestrogen-only HRT is only approved for women who have had their uterus removed. This is due to the fact that taking oestrogen alone increases the risk of endometrial cancer (cancer of the womb or uterus). If the consumer has had a hysterectomy, however, there is no longer a problem.